Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025)

Pulmonx has reported Asset Writedowns and Impairment over the past 7 years, most recently at $46000.0 for Q2 2025.

  • Quarterly Asset Writedowns and Impairment fell 97.29% to $46000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$200000.0 through Sep 2025, down 109.69% year-over-year, with the annual reading at $40000.0 for FY2024, 167.8% up from the prior year.
  • Asset Writedowns and Impairment was $46000.0 for Q2 2025 at Pulmonx, up from -$46000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.7 million in Q2 2024 and troughed at -$968000.0 in Q4 2021.
  • The 5-year median for Asset Writedowns and Impairment is $55000.0 (2022), against an average of $127388.9.
  • The largest YoY upside for Asset Writedowns and Impairment was 722.71% in 2024 against a maximum downside of 20100.0% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$968000.0 in 2021, then surged by 143.39% to $420000.0 in 2022, then crashed by 99.76% to $1000.0 in 2023, then tumbled by 20100.0% to -$200000.0 in 2024, then skyrocketed by 123.0% to $46000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Asset Writedowns and Impairment are $46000.0 (Q2 2025), -$46000.0 (Q1 2025), and -$200000.0 (Q4 2024).